3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine

C64H68BBrCl2F2N12O5 — CID 158498180

IUPAC3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine
SMILESCN(CCn1cc(B2OC(C)(C)C(C)(C)O2)cn1)C(=O)OC(C)(C)C.CNCCn1cc(-c2cnc3ccc(-c4cn[nH]c4-c4cc(Cl)ccc4F)cc3c2)cn1.Fc1ccc(Cl)cc1-c1nn(C2CCCCO2)cc1-c1ccc2ncc(Br)cc2c1
InChIInChI=1S/C24H20ClFN6.C23H18BrClFN3O.C17H30BN3O4/c1-27-6-7-32-14-18(12-30-32)17-9-16-8-15(2-5-23(16)28-11-17)21-13-29-31-24(21)20-10-19(25)3-4-22(20)26;24-16-10-15-9-14(4-7-21(15)27-12-16)19-13-29(22-3-1-2-8-30-22)28-23(19)18-11-17(25)5-6-20(18)26;1-15(2,3)23-14(22)20(8)9-10-21-12-13(11-19-21)18-24-16(4,5)17(6,7)25-18/h2-5,8-14,27H,6-7H2,1H3,(H,29,31);4-7,9-13,22H,1-3,8H2;11-12H,9-10H2,1-8H3
InChIKeyHJNZVSBMTGLQPF-UHFFFAOYSA-N
MW1284.94 g/mol
LogP14.24
Rot. Bonds13

About 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine

3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine (PubChem CID 158498180) has the molecular formula C64H68BBrCl2F2N12O5 and a molecular weight of 1284.94 g/mol. Its IUPAC name is 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine.

Molecular Properties

Compound Name3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine
PubChem CID158498180
Molecular FormulaC64H68BBrCl2F2N12O5
Molecular Weight1284.94 g/mol
Exact Mass1282.41
IUPAC Name3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine
SMILESCN(CCn1cc(B2OC(C)(C)C(C)(C)O2)cn1)C(=O)OC(C)(C)C.CNCCn1cc(-c2cnc3ccc(-c4cn[nH]c4-c4cc(Cl)ccc4F)cc3c2)cn1.Fc1ccc(Cl)cc1-c1nn(C2CCCCO2)cc1-c1ccc2ncc(Br)cc2c1
InChIInChI=1S/C24H20ClFN6.C23H18BrClFN3O.C17H30BN3O4/c1-27-6-7-32-14-18(12-30-32)17-9-16-8-15(2-5-23(16)28-11-17)21-13-29-31-24(21)20-10-19(25)3-4-22(20)26;24-16-10-15-9-14(4-7-21(15)27-12-16)19-13-29(22-3-1-2-8-30-22)28-23(19)18-11-17(25)5-6-20(18)26;1-15(2,3)23-14(22)20(8)9-10-21-12-13(11-19-21)18-24-16(4,5)17(6,7)25-18/h2-5,8-14,27H,6-7H2,1H3,(H,29,31);4-7,9-13,22H,1-3,8H2;11-12H,9-10H2,1-8H3
InChIKeyHJNZVSBMTGLQPF-UHFFFAOYSA-N
XLogP14.24
TPSA177.18 Ų
H-Bond Donors2
H-Bond Acceptors15
Rotatable Bonds13
Heavy Atoms87
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001284.94
LogP ≤ 514.24
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine?
The IUPAC name of 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine (CID 158498180) is 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine.
What is the SMILES notation for 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine?
The canonical SMILES for 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine is CN(CCn1cc(B2OC(C)(C)C(C)(C)O2)cn1)C(=O)OC(C)(C)C.CNCCn1cc(-c2cnc3ccc(-c4cn[nH]c4-c4cc(Cl)ccc4F)cc3c2)cn1.Fc1ccc(Cl)cc1-c1nn(C2CCCCO2)cc1-c1ccc2ncc(Br)cc2c1.
What is the InChIKey of 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine?
The InChIKey is HJNZVSBMTGLQPF-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H20ClFN6.C23H18BrClFN3O.C17H30BN3O4/c1-27-6-7-32-14-18(12-30-32)17-9-16-8-15(2-5-23(16)28-11-17)21-13-29-31-24(21)20-10-19(25)3-4-22(20)26;24-16-10-15-9-14(4-7-21(15)27-12-16)19-13-29(22-3-1-2-8-30-22)28-23(19)18-11-17(25)5-6-20(18)26;1-15(2,3)23-14(22)20(8)9-10-21-12-13(11-19-21)18-24-16(4,5)17(6,7)25-18/h2-5,8-14,27H,6-7H2,1H3,(H,29,31);4-7,9-13,22H,1-3,8H2;11-12H,9-10H2,1-8H3.
What are the key properties of 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine?
3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine has a molecular weight of 1284.94 g/mol, XLogP of 14.24, 13 rotatable bonds, 2 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-6-[3-(5-chloro-2-fluorophenyl)-1-(oxan-2-yl)pyrazol-4-yl]quinoline;tert-butyl N-methyl-N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]carbamate;2-[4-[6-[5-(5-chloro-2-fluorophenyl)-1H-pyrazol-4-yl]quinolin-3-yl]pyrazol-1-yl]-N-methylethanamine is sourced from PubChem (CID 158498180), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).